Report cover image

Diphtheria Vaccine Market, by Vaccine Type (DTaP vaccine, DT vaccine, Tdap vaccine, and Td vaccine), by Age Group (Pediatrics and Adults), by End User (Hospitals, Clinics, and Vaccination Centers), and by Region (North America, Latin America, Europe, Asia

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 190 Pages
SKU # CMI20008191

Description

Diphtheria is a serious infection caused by strains of bacteria called Corynebacterium diphtheriae that make a toxin. It is the toxin that can cause people to get sick. Diphtheria bacteria spread from person to person, usually through respiratory droplets, like from coughing or sneezing. The bacteria make a toxin that kills healthy tissues in the respiratory system. Within two to three days, the dead tissue forms a thick, gray coating that can build up in the throat or nose. Vaccines are available that help prevent diphtheria, an infection caused by Corynebacterium diphtheriae bacteria. There are four kinds of Vaccines used in the U.S. to protect against diphtheria, all of which also provide protection against other diseases such as tetanus, and pertussis. The Vaccines are as follow: Diphtheria and tetanus (DT) Vaccines, Diphtheria, tetanus, and pertussis (DTaP) Vaccines, Tetanus and diphtheria (Td) Vaccines, and Tetanus, diphtheria, and pertussis (Tdap) Vaccines.

Market Dynamics

Increase in the government and non-government organizations initiatives to develop diphtheria Vaccines and increase in the awareness among people regarding importance of diphtheria Vaccine is expected to drive the market growth. Moreover, increase in the prevalence of bacterial infection such as diphtheria and tetanus is expected to drive the market growth for the forecast period. For instance, according to an article published in national library of medicine in June 2021, there were around 2,243 cases of diphtheria in Middle East during the period between 2019 to 2020. Out of which, about 44% (978/2243, 43.6%) of the cases involved children aged 5 to 15 years. Respiratory tract infection was the predominant symptom (2044/2243, 91.1%), followed by pseudomembrane (1822/2243, 81.2%).

Key features of the study:
  • This report provides in-depth analysis of the global diphtheria vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global diphtheria vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AJ Vaccines A/S., BIONET-ASIA, GlaxoSmithKline plc., MassBiologics, Meiji Holdings Co., Ltd., Merck & Co., Inc, Panacea Biotec, Sanofi, Serum Institute of India Pvt. Ltd., Bharat Biotech, and BB – NCIPD Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global diphtheria vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diphtheria vaccine market
Detailed Segmentation:
  • Global Diphtheria Vaccine Market, By Vaccine Type:
  • DTaP Vaccine
  • DT Vaccine
  • Tdap Vaccine
  • Td Vaccine
  • Global Diphtheria Vaccine Market, By Age Group:
  • Pediatrics
  • Adults
  • Global Diphtheria Vaccine Market By End User:
  • Hospitals
  • Clinics
  • Vaccination Centers
  • Global Diphtheria Vaccine Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • AJ Vaccines A/S.
  • BIONET-ASIA
  • GlaxoSmithKline plc.
  • MassBiologics
  • Meiji Holdings Co., Ltd.
  • Merck & Co., Inc
  • Panacea Biotec
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Bharat Biotech
  • BB – NCIPD Ltd.

Table of Contents

190 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Vaccine Type
Market Snapshot, By Age Group
Market Snapshot, By End User
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Merger, Acquisition, Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
Pipeline Analysis
Technological Advancement
4. Global Diphtheria Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global Diphtheria Vaccine Market, By Vaccine Type, 2020 – 2032, (US$ Million)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
DTaP Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
DT Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Tdap Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Td Vaccine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
6. Global Diphtheria Vaccine Market, By Age Group, 2020 – 2032, (US$ Million)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segment Trends
Paediatrics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
7. Global Diphtheria Vaccine Market, By End User, 2020 – 2032, (US$ Million
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 – 2032
Segments Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
Vaccination Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Million)
8. Global Diphtheria Vaccine Market, By Region, 2020 – 2032, (US$ Million)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Million)
North Africa
Central Africa
South Africa
9. Competitive Landscape
AJ Vaccines A/S.*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
BIONET-ASIA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
GlaxoSmithKline plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
MassBiologics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Meiji Holdings Co., Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Merck & Co., Inc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Panacea Biotec
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Serum Institute of India Pvt. Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bharat Biotech
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
BB – NCIPD Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About Us
*Browse 34 market data tables and 30 figures on “Global Diphtheria Vaccine Market” - Global forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us